In the modern study, we claimed the identification as well as characterization of a different atypical opioid receptor with special unfavorable regulatory properties toward opioid peptides.1 Our success confirmed that ACKR3/CXCR7, hitherto often known as an atypical scavenger receptor for chemokines CXCL12 and CXCL11, can also be a broad-spectrum https://whatischronicpain92332.tribunablog.com/conolidine-an-overview-43779853